CHSCP CHS Forecast, Technical & Fundamental Analysis

CHSCP in upward trend: price may jump up because it broke its lower Bollinger Band on September 21, 2026

CHSCP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 11 of 31 cases where CHSCP's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 35%.

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a +0.53% 3-day Advance, the price is estimated to grow further. Considering data from situations where CHSCP advanced for three days, in 58 of 321 cases, the price rose further within the following month. The odds of a continued upward trend are 18%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CHSCP as a result. In 26 of 101 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 26%.

The Moving Average Convergence Divergence Histogram (MACD) for CHSCP turned negative on September 21, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In 10 of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at 19%.

CHSCP moved below its 50-day moving average on September 18, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CHSCP crossed bearishly below the 50-day moving average on September 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 7 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 44%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CHSCP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 20%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 2 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (2.869). P/E Ratio (0.000) is within average values for comparable stocks, (34.268). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.447). CHSCP has a moderately high Dividend Yield (0.077) as compared to the industry average of (0.034). P/S Ratio (0.000) is also within normal values, averaging (2.353).

The Tickeron Price Growth Rating for this company is 68 (best 1 - 100 worst), indicating slightly worse than average price growth. CHSCP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 94 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CHSCP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.